Drug recall

Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only…

FDA recall event 96718 · Class II · Eugia US LLC

Key facts

Event ID 96718
Recall numbers D-0389-2025, D-0390-2025
Recalling firm Eugia US LLC
Product type Drugs
Products Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ…, Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520…
Classification Class II
Status Ongoing
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
Initiation date Apr 21, 2025
Report date May 7, 2025
City East Windsor
State NJ
Country United States
FEI number 3014054088

At a glance

  • 1–9 Products in this recall
  • None FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls